chrX-50910945-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_Very_StrongBP7BS2_Supporting
The NM_005448.2(BMP15):c.162C>T(p.Gly54=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000822 in 1,192,935 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 32 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., 4 hem., cov: 23)
Exomes 𝑓: 0.000080 ( 0 hom. 28 hem. )
Consequence
BMP15
NM_005448.2 synonymous
NM_005448.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.332
Genes affected
BMP15 (HGNC:1068): (bone morphogenetic protein 15) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate subunits of a disulfide-linked homodimer, or alternatively, a heterodimer, with the related protein, growth differentiation factor 9 (GDF9). This protein plays a role in oocyte maturation and follicular development, through activation of granulosa cells. Defects in this gene are the cause of ovarian dysgenesis and are associated with premature ovarian failure. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant X-50910945-C-T is Benign according to our data. Variant chrX-50910945-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 914978.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-50910945-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.332 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 4 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMP15 | NM_005448.2 | c.162C>T | p.Gly54= | synonymous_variant | 1/2 | ENST00000252677.4 | NP_005439.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMP15 | ENST00000252677.4 | c.162C>T | p.Gly54= | synonymous_variant | 1/2 | 1 | NM_005448.2 | ENSP00000252677 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 112447Hom.: 0 Cov.: 23 AF XY: 0.000116 AC XY: 4AN XY: 34619
GnomAD3 genomes
AF:
AC:
12
AN:
112447
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
34619
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000149 AC: 22AN: 147482Hom.: 0 AF XY: 0.000155 AC XY: 7AN XY: 45036
GnomAD3 exomes
AF:
AC:
22
AN:
147482
Hom.:
AF XY:
AC XY:
7
AN XY:
45036
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000796 AC: 86AN: 1080434Hom.: 0 Cov.: 33 AF XY: 0.0000797 AC XY: 28AN XY: 351460
GnomAD4 exome
AF:
AC:
86
AN:
1080434
Hom.:
Cov.:
33
AF XY:
AC XY:
28
AN XY:
351460
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000107 AC: 12AN: 112501Hom.: 0 Cov.: 23 AF XY: 0.000115 AC XY: 4AN XY: 34683
GnomAD4 genome
AF:
AC:
12
AN:
112501
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
34683
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ovarian dysgenesis 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 26, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | BMP15: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at